MLTX
Price
$15.76
Change
-$0.11 (-0.69%)
Updated
Aug 21 closing price
Capitalization
1.34B
86 days until earnings call
Intraday BUY SELL Signals
PRLD
Price
$6.63
Change
+$0.13 (+2.00%)
Updated
Aug 21 closing price
Capitalization
529.1M
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs PRLD

MLTX vs PRLD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MLTX vs. PRLD commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (MLTX: $15.76 vs. PRLD: $6.63)
Brand notoriety: MLTX and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 89% vs. PRLD: 86%
Market capitalization -- MLTX: $1.34B vs. PRLD: $529.1M
MLTX [@Biotechnology] is valued at $1.34B. PRLD’s [@Biotechnology] market capitalization is $529.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 1 FA rating(s) are green whilePRLD’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 1 green, 4 red.
  • PRLD’s FA Score: 0 green, 5 red.
According to our system of comparison, PRLD is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 3 TA indicator(s) are bullish while PRLD’s TA Score has 6 bullish TA indicator(s).

  • MLTX’s TA Score: 3 bullish, 5 bearish.
  • PRLD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -4.31% price change this week, while PRLD (@Biotechnology) price change was +19.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 17, 2026.

PRLD is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($1.34B) has a higher market cap than PRLD($529M). PRLD YTD gains are higher at: 128.621 vs. MLTX (19.575). PRLD has higher annual earnings (EBITDA): -82.47M vs. MLTX (-245.81M). MLTX has more cash in the bank: 358M vs. PRLD (81.6M). PRLD has less debt than MLTX: PRLD (17.7M) vs MLTX (101M). PRLD has higher revenues than MLTX: PRLD (16.7M) vs MLTX (0).
MLTXPRLDMLTX / PRLD
Capitalization1.34B529M253%
EBITDA-245.81M-82.47M298%
Gain YTD19.575128.62115%
P/E RatioN/AN/A-
Revenue016.7M-
Total Cash358M81.6M439%
Total Debt101M17.7M571%
FUNDAMENTALS RATINGS
MLTX vs PRLD: Fundamental Ratings
MLTX
PRLD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
40
Fair valued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8234
P/E GROWTH RATING
1..100
10091
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MLTX's Valuation (25) in the null industry is in the same range as PRLD (40). This means that MLTX’s stock grew similarly to PRLD’s over the last 12 months.

MLTX's Profit vs Risk Rating (92) in the null industry is in the same range as PRLD (100). This means that MLTX’s stock grew similarly to PRLD’s over the last 12 months.

MLTX's SMR Rating (99) in the null industry is in the same range as PRLD (100). This means that MLTX’s stock grew similarly to PRLD’s over the last 12 months.

PRLD's Price Growth Rating (34) in the null industry is somewhat better than the same rating for MLTX (82). This means that PRLD’s stock grew somewhat faster than MLTX’s over the last 12 months.

PRLD's P/E Growth Rating (91) in the null industry is in the same range as MLTX (100). This means that PRLD’s stock grew similarly to MLTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MLTXPRLD
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
85%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 21 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LFSFX33.710.48
+1.44%
Lord Abbett Focused Small Cap Value F
AVDNX18.060.19
+1.06%
Avantis® International Equity G
BBIEX16.430.17
+1.05%
Bridge Builder International Equity
MNHRX27.240.17
+0.63%
Manning & Napier Pro-Blend Max Term R
FBMCX13.500.01
+0.07%
Franklin Managed Income C

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with SRPT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+2.00%
SRPT - PRLD
38%
Loosely correlated
-2.24%
NAUT - PRLD
36%
Loosely correlated
+5.79%
MLTX - PRLD
35%
Loosely correlated
-0.69%
AMRN - PRLD
35%
Loosely correlated
+0.21%
AXON - PRLD
35%
Loosely correlated
+2.20%
More